Actively Recruiting

Phase Not Applicable
Age: 65Years +
All Genders
NCT06676644

Estimate the Safety and Effectiveness of Adjuvanted Influenza Vaccine Among Asian Elderly People When Compared to Non-adjuvanted Vaccines

Led by National Taiwan University Hospital · Updated on 2026-02-24

200

Participants Needed

1

Research Sites

162 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

To compare the immunogenicity, cellular immune response, and safety between adjuvanted (aIIV4) and non-adjuvanted (IIV4) seasonal influenza vaccines in the Taiwanese elderly population with chronic medical conditions.

CONDITIONS

Official Title

Estimate the Safety and Effectiveness of Adjuvanted Influenza Vaccine Among Asian Elderly People When Compared to Non-adjuvanted Vaccines

Who Can Participate

Age: 65Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 65 years or above
  • Presence of at least 1 chronic medical condition that increases risk of complicated influenza, including hypertension, chronic obstructive pulmonary disease (group A, B, E), asthma, congestive heart failure (ACC/AHA stage A, B, C, D), coronary arterial disease, diabetes mellitus, chronic liver disease (Child-Pugh score A, B, C), chronic kidney disease (stage 1~4), neuromuscular disorders, hematological or solid organ malignancies, or recipients of hematopoietic stem cell or solid organ transplantation
Not Eligible

You will not qualify if you...

  • History of severe adverse event after influenza vaccination, such as anaphylaxis or Guillain-Barré Syndrome, or severe bleeding tendency
  • Influenza vaccination received during the current flu season
  • Determination by the Principal Investigator that the participant is ineligible based on clinical assessment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

National Taiwan University Hospital

Taipei, Taiwan, 100225

Actively Recruiting

Loading map...

Research Team

J

Jann-Tay Wang Clinical Professor, M. D., Ph.D.

CONTACT

U

Un-In Wu Clinical Associate Professor, M. D.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here